COR — Cencora Inc. stock price and chart

COR

Cencora Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.09% · Russell 1000 0.08% · US Stock Market 0.07% · Russell 3000 0.07% · MSCI ACWI 0.06% · MSCI World 0.05%

$321.57+0.19%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

100.0150.0200.0250.0300.0350.0020.0M$321.57

2026-09-11

Price$321.57

MA20$301.96

MA50$317.93

Vol7.7M

What would $1,000 invested in COR be worth today? →

COR returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $321.57
Change YTD: -4.22%
Next earnings: Nov 4, 2026
Market cap: 61.4B2016-09 17.8B2026-09 61.3B+244.9% over the window
Enterprise value: 72.1B
Shares outstanding: 190.8M2016-06 214.7M2026-06 190.8M-11.1% over the window
52W low: $244.82
52W high: $377.54
From 52W high: -14.82%
From 52W low: +31.35%
52W range: 58%
Beta: 0.57

Volume

Rel volume: 0.59×
30D volume: 1.4M
30D $ vol: 450.9M

Fundamentals

Sales (ttm): 332.8B2016-06 144.8B2026-06 332.8B+129.9% over the window
Sales/share: $1,743.842016-06 $674.132026-06 $1,743.84+158.7% over the window
EPS (ttm): $13.462016-06 $7.242026-06 $13.46+85.9% over the window
FCF (ttm): 4.1B2016-06 2.6B2026-06 4.1B+56.1% over the window
FCF/share: $21.282016-06 $12.112026-06 $21.28+75.6% over the window
Book value/share: $15.992016-06 $8.752026-06 $15.99+82.7% over the window
Net margin: 0.79%2016-06 1.1%2026-06 0.8%-30.6% over the window
ROE: 86.03%2016-06 87.6%2026-06 86.0%-1.7% over the window
ROA: 3.13%2016-06 5.2%2026-06 3.1%-39.3% over the window
Debt / equity: 3.75×2016-06 2.022026-06 3.75+85.8% over the window
Current ratio: 0.932016-06 0.892026-06 0.93+4.5% over the window

Growth (CAGR, ttm) · 10Y

Sales: +5.09%2025-06-30 → 2026-06-30316.7B → 332.8B (+5.1% total)+9.36%2023-06-30 → 2026-06-30254.4B → 332.8B (+30.8% total)+10.25%2021-06-30 → 2026-06-30204.3B → 332.8B (+62.9% total)+8.68%2016-06-30 → 2026-06-30144.8B → 332.8B (+129.9% total)
Net income: +38.38%2025-06-30 → 2026-06-301.9B → 2.6B (+38.3% total)+15.82%2023-06-30 → 2026-06-301.7B → 2.6B (+55.4% total)n/a+4.78%2016-06-30 → 2026-06-301.6B → 2.6B (+59.5% total)
FCF: +255.96%2025-06-30 → 2026-06-301.1B → 4.1B (+255.7% total)+13.28%2023-06-30 → 2026-06-302.8B → 4.1B (+45.4% total)+9.63%2021-06-30 → 2026-06-302.6B → 4.1B (+58.3% total)+4.55%2016-06-30 → 2026-06-302.6B → 4.1B (+56.1% total)
Shares: -1.57%2025-06-30 → 2026-06-30193.9M → 190.8M (-1.6% total)-1.91%2023-06-30 → 2026-06-30202.2M → 190.8M (-5.6% total)-1.69%2021-06-30 → 2026-06-30207.8M → 190.8M (-8.2% total)-1.17%2016-06-30 → 2026-06-30214.7M → 190.8M (-11.1% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +39.01%2025-06-30 → 2026-06-30$9.69 → $13.46 (+39.0% total)+18.00%2023-06-30 → 2026-06-30$8.19 → $13.46 (+64.3% total)n/a+6.40%2016-06-30 → 2026-06-30$7.24 → $13.46 (+85.9% total)
Sales/share: +6.77%2025-06-30 → 2026-06-30$1,633.27 → $1,743.84 (+6.8% total)+11.48%2023-06-30 → 2026-06-30$1,258.44 → $1,743.84 (+38.6% total)+12.14%2021-06-30 → 2026-06-30$983.32 → $1,743.84 (+77.3% total)+9.97%2016-06-30 → 2026-06-30$674.13 → $1,743.84 (+158.7% total)
FCF/share: +261.66%2025-06-30 → 2026-06-30$5.89 → $21.28 (+261.3% total)+15.49%2023-06-30 → 2026-06-30$13.81 → $21.28 (+54.0% total)+11.51%2021-06-30 → 2026-06-30$12.34 → $21.28 (+72.4% total)+5.79%2016-06-30 → 2026-06-30$12.11 → $21.28 (+75.6% total)
Book value/share: +56.58%2025-06-30 → 2026-06-30$10.21 → $15.99 (+56.5% total)+67.63%2023-06-30 → 2026-06-30$3.39 → $15.99 (+371.2% total)+144.61%2021-06-30 → 2026-06-30$0.18 → $15.99 (+8651.2% total)+6.21%2016-06-30 → 2026-06-30$8.75 → $15.99 (+82.7% total)
Dividend/share: +8.80%2025-06-30 → 2026-06-30$2.16 → $2.35 (+8.8% total)+7.06%2023-06-30 → 2026-06-30$1.92 → $2.35 (+22.7% total)+6.20%2021-06-30 → 2026-06-30$1.74 → $2.35 (+35.1% total)+6.02%2016-06-30 → 2026-06-30$1.31 → $2.35 (+79.4% total)
Price: +6.20%2025-09-11 → 2026-09-11$302.80 → $321.57 (+6.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+21.85%2023-09-11 → 2026-09-11$177.73 → $321.57 (+80.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+21.22%2021-09-10 → 2026-09-11$122.81 → $321.57 (+161.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+14.18%2016-09-09 → 2026-09-11$85.31 → $321.57 (+276.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +7.01%2025-09-11 → 2026-09-11$300.51 → $321.57 (+7.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+22.87%2023-09-11 → 2026-09-11$173.33 → $321.57 (+85.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+22.96%2021-09-10 → 2026-09-11$114.36 → $321.57 (+181.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+16.70%2016-09-09 → 2026-09-11$68.59 → $321.57 (+368.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 23.9×2016-09 12.452026-09 23.37+87.7% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 20.2×2016-09 11.652026-09 20.16+73.0% over the window
Fwd P/E: 16.4×
P/S (ttm)Market cap ÷ TTM revenue.: 0.2×2016-09 0.122026-09 0.18+52.2% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 20.1×2016-09 8.352026-09 20.10+140.8% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 15.1×2016-09 6.552026-09 15.11+130.6% over the window
EV/EBITDA (fy): 17.7×
EV/Sales (ttm): 0.2×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.62%2016-06 14.6%2026-06 7.5%-48.7% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 0.73%
Dividend/share (fwd): $2.35
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 190.8M ÷ 193.9M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 1.57%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (1.57%) + dividends paid over that year ($468.1M) ÷ market_cap_at(2025-06-30) ($58.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 2.38%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($435.5M) ÷ today's market cap ($61.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.71%2016-06 11.7%2025-09 0.7%-93.9% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $435.5M + TTM dividends $468.1M) ÷ today's market cap ($61.4B). Same caveat as the cash buyback yield.: 1.47%2016-06 13.3%2025-09 1.4%-89.2% over the window

Vs own 10Y history

P/E: 66th
P/OI: 78th
P/S: 93rd
P/B: 51st
P/FCF: 64th

Bar = where today’s multiple sits in COR’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

+0.19%

-4.64%

+2.55%

+14.46%

YTD

-4.22%

+9.35%

+176.32%

Financial statements

Open full COR financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

Cencora Inc. (COR) trades at $321.57 with a live price and an interactive chart covering 31+ years of daily price history, plus key valuation metrics. ChartRow also publishes COR’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full COR financial statements →

COR — Cencora Inc. price, chart and key statistics